Filter Results
:
(2,143)
Show Results For
-
All HBS Web
(4,545)
- People (16)
- News (1,465)
- Research (2,143)
- Events (3)
- Multimedia (130)
- Faculty Publications (1,503)
Show Results For
-
All HBS Web
(4,545)
- People (16)
- News (1,465)
- Research (2,143)
- Events (3)
- Multimedia (130)
- Faculty Publications (1,503)
Sort by
- August 2013 (Revised October 2013)
- Case
MedImmune Ventures
By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer...
View Details
Keywords:
MedImmune;
MedImmune Ventures;
AstraZeneca;
NeuProtect;
Corporate Venturing;
Biotechnology;
Venture Investing;
Venture Capital;
Health Care and Treatment;
Pharmaceutical Industry;
Financial Services Industry;
Biotechnology Industry;
United States;
Australia;
Europe;
London
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
- 17 Jan 2012
- First Look
First Look: January 17
presents one home healthcare organization's efforts to use telemonitoring to improve the quality of care provided to at-risk patients who were discharged from hospitals and...
View Details
Keywords:
Sean Silverthorne
- August 2017
- Article
Relationship Between Labor and Delivery Unit Management Practices and Maternal Outcomes
By: Avery C. Plough, Grace Galwin, Zhonghe Li, Stuart R. Lipsitz, Shehnaz Alidina, Natalie J. Henrich, Lisa R. Hirschhorn, William R. Berry, Atul A. Gawande, Doris Peter, Rory McDonald, Donna L. Caldwell, Janet H. Muri, Debra Bingham, Aaron B. Caughey, Eugene R. Declercq and Neel T. Shah
OBJECTIVE: To define, measure, and characterize key competencies of managing labor and delivery units in the United States and assess the associations between unit management and maternal outcomes.
METHODS: We developed and administered a management measurement...
View Details
Keywords:
Health Care and Treatment;
Management Practices and Processes;
Performance Evaluation;
Outcome or Result;
United States
Plough, Avery C., Grace Galwin, Zhonghe Li, Stuart R. Lipsitz, Shehnaz Alidina, Natalie J. Henrich, Lisa R. Hirschhorn, William R. Berry, Atul A. Gawande, Doris Peter, Rory McDonald, Donna L. Caldwell, Janet H. Muri, Debra Bingham, Aaron B. Caughey, Eugene R. Declercq, and Neel T. Shah. "Relationship Between Labor and Delivery Unit Management Practices and Maternal Outcomes." Obstetrics & Gynecology 130, no. 2 (August 2017): 358–365.
- 05 Jul 2006
- First Look
First Look: July 5, 2006
MaterialsAncora: A Private University in the Health Care of the Poor 306-088 Project Ancora signals the entry of the private sector into primary...
View Details
Keywords:
Sean Silverthorne
- August 2008 (Revised September 2008)
- Supplement
The Flaxil Label (C): Debrief and Endnotes
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite...
View Details
Keywords:
Safety;
Value Creation;
Negotiation;
Health Care and Treatment;
Sales;
Pharmaceutical Industry
Barron, Greg M. "The Flaxil Label (C): Debrief and Endnotes." Harvard Business School Supplement 909-003, August 2008. (Revised September 2008.)
- 04 Apr 2017
- First Look
First Look at New Research, April 4
healthcare providers with revenue cycle management and population health management; the case provides an overview of both sectors. Conifer has been growing rapidly, leading some to question what the best...
View Details
Keywords:
Sean Silverthorne
- 17 Mar 2009
- First Look
First Look: March 17, 2009
small IT consulting firm, Exeter needs to make careful choices about how it allocates resources to projects, and it is not clear if the firm has the capacity to add all four projects at once. Thus Kutchins and Cullen have to decide which,...
View Details
Keywords:
Martha Lagace
- April 2006 (Revised May 2009)
- Case
Inverness Medical Innovations - Born Global (A)
Ron Zwanziger has just started his third company, having just sold the last one for $1.3 billion to Johnson & Johnson. As part of the deal with J&J, certain assets were transferred to the new company, Inverness Medical Innovations, which, at the time of its creation,...
View Details
Keywords:
Globalized Firms and Management;
Mergers and Acquisitions;
Entrepreneurship;
Health Care and Treatment;
Corporate Finance;
Health Industry;
Health Industry;
Waltham
Isenberg, Daniel J. "Inverness Medical Innovations - Born Global (A)." Harvard Business School Case 806-177, April 2006. (Revised May 2009.)
- 24 Apr 2007
- First Look
First Look: April 24, 2007
traditional handicraft artisans in rural India. Established in 1960 as an exporter of home furnishings, Fabindia has grown as a consumer-facing retailer of apparel, home furnishings, organic food, and body...
View Details
Keywords:
Sean Silverthorne
- 08 Sep 2020
- Sharpening Your Skills
Capitalism Works Better When I Can See What You're Doing
corrupt company. Why American Health Care Needs Its Own SECThe United States needs a health care equivalent of the...
View Details
Keywords:
by Sean Silverthorne
- 06 May 2014
- First Look
First Look: May 6
GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive...
View Details
Keywords:
Sean Silverthorne
- 26 Jul 2016
- First Look
July 26, 2016
Thomas W. Feeley, Diana J. Mason, Richard L. Schilsky, Ellen L. Stovall, and Shelley Fuld Nasso Abstract—"What Health System Transformations Do You Believe Are Necessary for the Future of View Details
Keywords:
Sean Silverthorne
- 23 May 2011
- Research & Ideas
Corporate Sustainability Reporting: It’s Effective
change in the social awareness of investors in the past decade. "The number of investors who care about this kind of performance has increased...
View Details
Keywords:
by Michael Blanding
- 10 Oct 2000
- Research & Ideas
Cross-Sector Collaboration: Lessons from the International Trachoma Initiative
The aim, write the authors, is "to deepen our understanding of the process of cross-sector collaboration in the public health arena and the factors contributing to...
View Details
- October 2013 (Revised January 2014)
- Supplement
Fred Khosravi and AccessClosure (B)
By: Richard G. Hamermesh and Lauren Barley
It was January 2013, and Fred Khosravi, chairman of the board of AccessClosure Inc., wondered what the new year had in store for him and AccessClosure, the company he founded in late 2002. Khosravi was cautiously optimistic—the Mountain View, California-based medical...
View Details
Keywords:
Medical Devices;
Vascular Closure Device;
Patent Litigation;
Patenting;
Biomedical Research;
Biotechnology;
Biotech;
Technological Innovation;
Patents;
Health Care and Treatment;
Biotechnology Industry;
United States;
California
Hamermesh, Richard G., and Lauren Barley. "Fred Khosravi and AccessClosure (B)." Harvard Business School Supplement 814-038, October 2013. (Revised January 2014.)
- August 2024
- Article
How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?
By: Leemore S. Dafny, Kate Ho and Edward Kong
Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by...
View Details
Keywords:
Prescription Drugs;
Coupons;
Impact;
Health Care and Treatment;
Markets;
Price;
Spending;
Pharmaceutical Industry;
United States
Dafny, Leemore S., Kate Ho, and Edward Kong. "How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?" American Economic Journal: Economic Policy 16, no. 3 (August 2024): 314–346.
- 14 Apr 2015
- First Look
First Look: April 14
factors such as "firm culture" and "employee engagement" in driving firm performance? Increasing evidence from a wide range of fields suggests that productivity differs widely across firms, even after the inclusion...
View Details
Keywords:
Sean Silverthorne
- Article
Believe in Vaccine Bets Like Bill Gates's
Commitment of public or private funds upfront speeds development, production, and distribution.
View Details
Keywords:
Coronavirus;
Vaccine;
Financing;
Health Pandemics;
Health Care and Treatment;
Product Development;
Production;
Distribution
Kominers, Scott Duke. "Believe in Vaccine Bets Like Bill Gates's." Bloomberg Opinion (April 28, 2020).
- 03 Jul 2012
- First Look
First Look: July 3
details Schön Klinik's founding, its early focus on measurement and improvement, and the design and implementation of a system-wide structure for measuring and reporting actual health outcomes. The case...
View Details
Keywords:
Sean Silverthorne
- October 2013 (Revised April 2015)
- Case
Myomo: Getting Sales in Motion
By: Frank V. Cespedes, Shikhar Ghosh and Matthew Preble
In late 2012, the management team of Myomo, a startup which had designed a unique myoelectric arm brace for patients with dysfunctional arms, was deciding which of the three sales models the company had tested to pursue as its sales strategy going forward. Each model...
View Details
Keywords:
Technological Innovation;
Information Technology;
Marketing Strategy;
Decision Choices and Conditions;
Health Care and Treatment;
Business Startups;
Sales;
Growth and Development Strategy;
Health Industry;
Health Industry
Cespedes, Frank V., Shikhar Ghosh, and Matthew Preble. "Myomo: Getting Sales in Motion." Harvard Business School Case 814-034, October 2013. (Revised April 2015.)